THE CHINWAGY BUZZ · FIRST VERIFIED WORD
Astellas and Vir Biotechnology enter global collaboration for VIR-5500
WHAT CHINWAGY KNOWS
The collaboration
is confirmed.
Astellas and Vir Biotechnology entered a global strategic collaboration to co-develop and co-commercialize VIR-5500, a PSMA-targeting dual-masked T-cell engager for prostate cancer.
- Current status
- Official collaboration
- Known availability
- Started 2026-02-23; the official source does not state an end date.
- Place
- International, Global
- Source checked
- September 13, 2026
FOLLOW THE STORY